logo

Cns Pharmaceuticals Inc (CNSP)



Trade CNSP now with
  Date
  Headline
1/6/2022 7:17:57 AM CNS Pharma Announces $11.5 Mln Private Placement Priced At-the-Market Under Nasdaq Rules
12/2/2021 8:37:30 AM CNS Gets Approval From Switzerland Ethics Committee For Potentially Pivotal Study Of Berubicin For Treatment Of GBM
9/30/2021 8:08:25 AM CNS Doses First Group Of Patients With Berubicin In Potentially Pivotal Study For Treatment Of Glioblastoma Multiforme
7/1/2021 9:06:45 AM CNS To Execute On Corporate, Regulatory Strategies To Drive Berubicin Towards Commercialization For Treatment Of GBM
6/29/2021 8:36:32 AM CNS Pharma: FDA Grants Fast Track Designation For Berubicin For Treatment Of Recurrent Glioblastoma Multiforme
5/19/2021 8:17:37 AM CNS Pharmaceuticals Opens Enrollment For Potentially Pivotal Study Evaluating Berubicin In Treatment Of Recurrent GBM
12/23/2020 8:32:45 AM CNS Pharmaceuticals Prices $10.0 Mln Public Offering
12/17/2020 9:10:53 AM CNS Pharma Says FDA Oks IND Application For Brain Cancer Drug Candidate Berubicin; Stock Surges
11/17/2020 8:07:28 AM CNS Pharmaceuticals Submits IND Application To FDA For Berubicin
10/29/2020 8:18:14 AM CNS Pharma Says Completes Manufacturing Of Berubicin For Phase 2 Clinical Trial